Thomas G. Hazel

Biography

Dr. Thomas G. Hazel, Tom, Ph.D. has been Senior Vice President of Research at Neuralstem, Inc since 2008. Dr. Hazel served as an Executive Vice President of Research of Neuralstem, Inc. since July 2008. Dr. Hazel manages Neuralstem's upcoming clinical trial for ALS (Amytrophic Lateral Sclerosis, or Lou Gehrig's disease), and complete development of Neuralstem's small molecule neurogenesis compound targeted to treat depression. Before Neuralstem in 1998, Dr. Hazel was a Senior Staff Scientist at the National Institute of Health. He came to Neuralstem after a four year stint as Chief Science Officer at Innovative Biosensors, Inc., in Maryland. He also served as Senior Director for Research and Development of Innovative Biosensors Inc. Dr. Hazel has over 12 years of laboratory research and management experience. He has held senior level research positions in a wide range of fields, including molecular genetics and cell culture. Dr. Hazel's area of expertise includes engineering of human cell lines and the manufacturing and storage of cell culture based reagents. He is named on several pending patents and has over 10 scientific publications. Dr. Hazel received a Ph.D. in Genetics from The University of Illinois College of Medicine and completed his postdoctoral work at the NIH.

Research Interest

Biotechnology